
Are you looking to buy Baxter International stocks? Chech our BAMagazine with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy NYSE:BAX! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about Baxter International stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. It also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.
Average volume
2.78 million shs
MARKET CAP
$39.67 billion
Stock exchange
NYSE
Buy this stock!
Below is a quick guide on how to buy NYSE:BAX stocks safe, fast and around the world in less than five minutes.
Step 1: Open an account with eToro – eToro is the best broker to buy Baxter International shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Step 2: Upload your ID – As per KYC regulations eToro will ask you to upload a copy of your passport or driver’s license.
Step 3: Deposit Funds – Deposit some money into your newly created eToro account. You can choose between wire transfer, e-wallet or debit/credit card or Paypal.
Step 4: Buy Baxter International – Search for “”NYSE:BAX”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought Baxter International stocks with 0% commission!.
1 | ![]() | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
16 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for Baxter International in the last year. There are currently 6 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should “buy” Baxter International stock.
Wall Street analysts have given Baxter International a “Buy” rating, but there may be better short-term opportunities in the market. Some of BAMagazine’s past winning trading ideas have resulted in 5-15% weekly gains. BAMagazine just released five new trading ideas, but Baxter International wasn’t one of them. BAMagazine thinks five stocks may be even better buys in the how to buy stocks guide.
1 | ![]() | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
2 | ![]() | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
3 | ![]() | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing NYSE:BAX stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy Baxter International stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy Baxter International stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Because eToro is a regulated platform, you’ll need to complete the KYC process, this is standard practice and only takes a couple of minutes. You’ll need to provide a photo ID (passport, driving licence) and proof of address (utility bill, bank statement).
Once you’ve signed up and verified your account, you’ll need to deposit funds. eToro accepts credit/debit cards, bank transfers, and also e-wallets. So whatever your preference there will be something for you.
Now that you’ve funded your eToro account, just type “NYSE:BAX stocks” into the search bar at the top of the screen and press “trade”.
All that’s left is to buy some NYSE:BAX stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, NYSE:BAX is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy Baxter International stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
Baxter International is scheduled to release its next quarterly earnings announcement on Thursday, April 29th 2021.
View our earnings forecast for Baxter International.
Baxter International Inc. (NYSE:BAX) posted its quarterly earnings results on Wednesday, February, 3rd. The medical instruments supplier reported $0.80 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.76 by $0.04. The medical instruments supplier had revenue of $3.18 billion for the quarter, compared to analysts’ expectations of $3.10 billion. Baxter International had a trailing twelve-month return on equity of 20.81% and a net margin of 7.90%. Baxter International’s revenue was up 4.7% compared to the same quarter last year. During the same period in the previous year, the company earned $0.97 EPS.
View Baxter International’s earnings history.
Baxter International’s stock was trading at $77.97 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, BAX shares have decreased by 0.6% and is now trading at $77.47.
Baxter International announced a quarterly dividend on Monday, November 16th. Shareholders of record on Friday, December 4th will be given a dividend of $0.245 per share on Monday, January 4th. This represents a $0.98 annualized dividend and a dividend yield of 1.27%. The ex-dividend date of this dividend is Thursday, December 3rd.
View Baxter International’s dividend history.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying NYSE:BAX stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Over 95% of client funds are kept offline, in cold storage, which is crucial for any broker that manages your assets. Regardless of how secure a platform is meant to be, we recommend using 2FA to add an additional layer of security to your account.
eToro offers users a range of features to start investing as quickly as possible. They have a relatively unique feature called copy trading, which lets you earn a passive income by mirroring experienced traders, this allows you to start earning profit quickly, and gives you a better understanding of the strategies used by professionals. Additionally, eToro allows users to invest in managed portfolios, a managed portfolio being a variety of similar assets grouped together, allowing you to diversify your account, reducing any potential risk. For those with previous trading experience, you can invest in markets outside of stocks, as eToro allows users to trade ETFs, commodities, crypto and indices. If you already invest outside of the stock market space this can be very useful, as it allows you to manage all your investments in just one place.
Baxter International pays an annual dividend of $0.98 per share and currently has a dividend yield of 1.27%. Baxter International has been increasing its dividend for 5 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio of Baxter International is 29.61%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Baxter International will have a dividend payout ratio of 28.49% next year. This indicates that Baxter International will be able to sustain or increase its dividend.
View Baxter International’s dividend history.
Baxter International issued an update on its FY21 earnings guidance on Thursday, February, 4th. The company provided earnings per share guidance of $3.35-3.43 for the period, compared to the Thomson Reuters consensus estimate of $3.49. The company issued revenue guidance of +7-8% (implying $12.5-12.6 billion), compared to the consensus revenue estimate of $12.17 billion.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
16 equities research analysts have issued 1 year target prices for Baxter International’s stock. Their forecasts range from $80.00 to $105.00. On average, they anticipate Baxter International’s stock price to reach $92.27 in the next twelve months. This suggests a possible upside of 19.1% from the stock’s current price.
View analysts’ price targets for Baxter International or view top-rated stocks among Wall Street analysts.
Baxter International saw a increase in short interest in December. As of December 31st, there was short interest totaling 6,670,000 shares, an increase of 29.0% from the December 15th total of 5,170,000 shares. Based on an average daily trading volume, of 3,170,000 shares, the days-to-cover ratio is presently 2.1 days. Approximately 1.3% of the company’s stock are sold short.
View Baxter International’s Short Interest.
Baxter International’s management team includes the following people:
Mr. José E. Almeida, Chairman, Pres & CEO (Age 59, Pay $2.12M)
Mr. James K. Saccaro, Exec. VP & CFO (Age 48, Pay $835.03k)
Mr. Sean B. W. Martin, Sr. VP & Gen. Counsel (Age 58, Pay $1.33M)
Mr. Giuseppe Accogli, Sr. VP & Pres of Americas and Global Bus. Units (Age 50, Pay $1.52M)
Mr. Cristiano Franzi, Sr. VP & Pres for EMEA (Age 58, Pay $1.5M)
Mr. Brian C. Stevens, Sr. VP, Chief Accounting Officer & Controller (Age 46)
Dr. Sumant Ramachandra, Pres of Pharmaceuticals and Sr. VP, Chief Science & Technology Officer (Age 52)
Mr. Talvis P. Love, Sr. VP & Chief Information Officer
Ms. Clare Trachtman, VP of Investor Relations
Ms. Jeanne K. Mason, Sr. VP of HR (Age 65)
506 employees have rated Baxter International CEO José (Joe) Almeida on Glassdoor.com. José (Joe) Almeida has an approval rating of 85% among Baxter International’s employees.
1 | ![]() | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
Some companies that are related to Baxter International include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton, Dickinson and (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), DexCom (DXCM), ResMed (RMD), Hologic (HOLX), Teleflex (TFX), Insulet (PODD), Varian Medical Systems (VAR) and STERIS (STE).
View all of BAX’s competitors.
Based on aggregate information from BAMagazine watchlists, some companies that other Baxter International investors own include CA (CA), Johnson & Johnson (JNJ), Pfizer (PFE), Cisco Systems (CSCO), Honeywell International (HON), Intel (INTC), Abbott Laboratories (ABT), The Procter & Gamble (PG), AT&T (T) and Verizon Communications (VZ).
Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol “BAX.”
Baxter International’s stock is owned by a number of institutional and retail investors. Top institutional investors include California Public Employees Retirement System (0.80%), Sumitomo Mitsui Trust Holdings Inc. (0.34%), New York State Teachers Retirement System (0.12%), Bartlett & Co. LLC (0.12%), Huntington National Bank (0.11%) and Marathon Asset Management LLP (0.11%). Company insiders that own Baxter International stock include Albert P L Stroucken, Andrew Frye, Giuseppe Accogli, Jacqueline Kunzler, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Sean Martin, Third Point Llc and Thomas T Stallkamp.
View institutional ownership trends for Baxter International.
BAX stock was sold by a variety of institutional investors in the last quarter, including PGGM Investments, Sumitomo Mitsui Trust Holdings Inc., Russell Investments Group Ltd., Dalton Greiner Hartman Maher & Co., New York State Teachers Retirement System, Marathon Asset Management LLP, Eos Focused Equity Management L.P., and US Bancorp DE. Company insiders that have sold Baxter International company stock in the last year include Albert P L Stroucken, Andrew Frye, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, and John D Forsyth.
View insider buying and selling activity for Baxter International or view top insider-selling stocks.
BAX stock was purchased by a variety of institutional investors in the last quarter, including California Public Employees Retirement System, Strategic Blueprint LLC, Bartlett & Co. LLC, Nisa Investment Advisors LLC, Meyer Handelman Co., Farmers & Merchants Investments Inc., Van Strum & Towne Inc., and Hartford Investment Management Co..
View insider buying and selling activity for Baxter International or or view top insider-buying stocks.
At BAMagazine.com we want to make sure that you have all the most relevant information about buying stocks. We bring you the best guides about the stock market with personal reviews, background information, platform reviews, how to’s and more. Want to get other information? Then check out the OTC stocks, NASDAQ stocks, NYSE stocks, LON stocks, FRA stocks, ETR stocks, EPA stocks, TSX stocks or Amex stocks. Looking for more detailed info like 5g stocks, biotech stocks, gold stocks and other information out of our reportlab.
How to buy Baxter International stocks?
The safest and easiest way to buy NYSE:BAX stocks is by using a regulated broker like eToro or DEGiro. You can open an account with the platform, make a deposit and buy this stock in under 5 minutes from start to finish.
Opening an account with one of these brokers is a smart move, they have been active for more then 10 years, are very safe to use and they have the best platform for novice and experienced traders. If you want to learn more then we suggest you to read our eToro or DeGiro guides.
Where to buy Baxter International stock?
You will first want to find a licensed broker that supports Baxter International stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading NYSE:BAX stocks in a safe and complete environment.
Is NYSE:BAX stock a good investment?
As with any other asset, there is an element of risk associated with buying NYSE:BAX stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is Baxter International stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with NYSE:BAX is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in Baxter International stock.
How do you trade Baxter International stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for Baxter International stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on NYSE:BAX stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell Baxter International stock?
To sell your NYSE:BAX stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best Baxter International stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading NYSE:BAX stock.
Stephen knows a lot about financial products and in particular has a great passion for the stock markets and its participants. We hope that the information provided will help you. Something not quite clear? Please leave your questions or comments at the bottom of the page.
![]() | Our score ★★★★★ | |
![]() | Our score ★★★★★ | |
![]() | Our score ★★★★★ |
Newsletter
![]() |
Our score |
0% commission |
Realtime Stocks & Crypto data
Notifications, Tips & News
Best Stocks & Crypto Guides
Online Broker & Exchange Reviews
BAMagazine Finance is purely an informative website and in no case implies investment advice. All investments carry risks and you can lose all your investments. Do not invest money that you cannot afford to lose.
BAMagazine Finance
38 Holburn Lane
Heckfield Green
IP21 0UB
United Kingdom
Copyright © 2022 BAMagazine.Finance | All rights reserved.